Hydrophobicity estimations of benzenesulfonamidofluoroquinolones (BSFQs) by RP-LC. Influence of chromatographic parameters in QSAR studies

Medicinal Chemistry Research

Volumn 12, Issue 2, 2003, Pages 94-110

  Nieto, Marcelo J ^a   Rodriguez Manzanares, Pablo A ^a   Manzo, Ruben H ^a   Mazzieri, María R ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENESULFONAMIDE DERIVATIVE; BENZENESULFONAMIDOFLUOROQUINOLONE DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; NONHUMAN; PARAMETER; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; STATISTICAL SIGNIFICANCE; THIN LAYER CHROMATOGRAPHY;

EID: 0346120044     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hansch C., Leo A. The Hydrophobic Parameter. Measurement and Calculation. In Exploring QSAR: Fundamentals and Applications in Chemistry and Biology. S.R. Heller (Ed.) ACS Professional Reference Book. American Chemical Society: Washington, USA, 1 1995, pp. 97-124.
2. Biagi G.L., Recanatini M., Barbara A.M., Guerra M.C., Sapone A., Borea P.A., Pietrogrande M.C., in Kalasz H., Ettre L.S. (Ed.), Chromatographic parameters as lipophilicity indices for Qsar studies. New Approaches in Chromatography '93, Fekete Sas Könyvkiadó, Budapest, 1993 pp. 215-234.
3. app=8. J. Chromatogr. 1993, 629, 123-134.
4. MW by reversed-phase thin.layer chromatography, J. Chromatogr. A. 1994, 673, 113-124.
5. oct values. QSAR 1998, 17 (6), 549-557.
6. Dorsey J.G., Khaledi M.G., Hydrophobicity estimations by reserverd-phase liquid chromatography. Implications for biological partitioning processes. J. Chromatogr. A 1993, 656, 485-499.
7. Cimpan G., Hadaruga M., Miclaus V., Lipophilicity characterization by reversed-phase liquid chromatography of some furan derivates, J. Chromatogr. A 2000, 869, 49-55.
8. Hooper D.C., Wolfson U.C. (Ed.) Quinolone Antimicrobial Agents, 2nd Edition. American Society for Microbiology: Washington, USA, 1993.
9. Allemandi D.A., Alovero F.L., Manzo R.H., In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus. J. Antimicr. Chemother. 1994, 34(2), 261-265.
10. 9a. Nieto M.J., Alovero F.L., Manzo R.H., Mazzieri M.R., A new class of antibacterials benzenosulfonylamidofluoroquinolones (BSFQs). Eur. J. Med. Chem. 1999, 34 (3), 209-214.
11. b) Nieto, M. Diseño, preparación y estudios de las Relaciones Estructura-Actividad de nuevos antimicrobianos fluoroquinoló nicos. Thesis dissertation. 1999. Universidad Nacional de Cordoba.
12. Alovero F.L., Nieto M.J., Mazzieri M.R., Then R., Manzo R.H., Mode of action of sulfanilyl fluoroquinolones (NSFQs). Antimicr. Agents Chemother. 1998, 42(6), 1495-1498.
13. Shen L.L., Mitscher L.A., Sharma P.N., O'Donnell T.J., Chu D.T.W., Cooper C.S., Rossen T., Pernet A.G., Mechanism of inhibition of DNA Gyrase by quinolone antibacterials: A cooperative drug-DNA binding model. Biochemistry 1989, 28(9), 3886-3894.
14. Klopman G., Macina O.T., Levinson M.E., Rosenkranz H.S., Computer automated structure evaluation of quinolone antibacterial agents. Antimicrob. Agents Chemother. 1987, 31(11), 1831-1840.
15. Frigola J., Torrens A., Castrillo J.A., Mas J., Vaño D., Berrocal J.M., Calvet C., Salgado L., Redondo J., García-Granda S., Valenti E., Quintana J.R., Azetidinylquinolones as antibacterial agents. 2. Synthesis and Biological activity of 7-(2,3-disubstituted-1-azetidinyl)-4-oxoquinoline-and -1,8-naphthyridine-3-carboxylic Acids. Properties and structure-activity relationships of quinolones with an azetidine moiety. J. Med. Chem. 1994, 37(24), 4195-4210.
16. Okada T., Ezumi K., Yamakawa M., Sato H., Tsuji T., Tsushima T., Motokawa K., Komatsu, Y., Quantitative structure-activity relationships of antibacterial agents, 7-heterocyclic amine substituted 1-cyclopropyl-6,8- difluoro-4-oxoqinoline-3-carboxylic acids. Chem. Pharm. Bull. 1993, 41, 126-131.
17. 1-substituents of quinolone antibacterials. J. Med. Chem. 1991, 34, 131-139.
18. Manzo R.H., Allemandi D.A., Perez J.D. Novel N-sulphanilyl derivatives. US patent 08,071,608; 1993.
19. Manzo, R.H., Mazzieri M.R., Nieto M.J., Alovero F.L., A new class of antibacterials benzenosulfonylamidofluoroquinolones (BSFQs). Argentine Patent Application P 97 01 00693, 1997.
20. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility test for bacteria that grows aerobically, 2nd edition. Approved standard M7-A2. Villanova, PA, USA. 1990.
21. Fallati C.S., Mazzieri M.R., Manzo R.H., Lipophilicity of zwitterionic and non-zwitterionic fluoroquinolone antibacterials. S.T.P. Pharma Sci. 1996, 6, 162-165.
22. Hansch C., Leo A., Hoekman D., in S.R. Heller (Ed.), Exploring QSAR: Hydrophobic, Electronic, and Steric Constants. Vol 2. ACS Professional Reference Book. American Chemical Society, Washington, USA, 1995.
23. Biagi G.L., Barbaro A.M., Sapone A., Recanatini M., Determination of lipophilicity by means of reversed-phase thin-layer chromatography. Basic aspects and relationships between slopes and intercept of TLC equations. J. Chromatogr. A, 1994, 662, 341-361.
24. Biagi G.L., Barbaro A.M., Recanatini M., Determination of lipophilicity by means of reversed-phase thin-layer chromatography. J. Chromatogr. A, 1994, 678, 127-137.
25. M values in reversed-phase thin-layer chromatography including aspects of pH dependence. J. Chromatogr. 1993, 639, 287-294.
26. Kuchar M., Kraus E., Jelinkova M., Influence of mobile phase composition on evaluation of lipophilicity by partition chromatography. J. Chromatogr. 1991, 557, 399-411.
27. Kubinyi H., Manholds R., Krogsgaard-Larsen H., Timmerman H., (Ed.), Methods and Principles in Medicinal Chemistry Vol 1, QSAR: Hansch Analysis and Related Approaches, VCH Publisher, New York, NY, USA, 1993.
28. Cabrera Pérez M., González Díaz H., Fernández Teruel C., Plá-Delfina J.M., Bermejo Sanz M., A Novel Approach to determining Physicochemical and Absorption Properties of 6-Fluoroqyuinolones derivatives: Experimental Assessment. Eur. J. Pharm. Biopharm. 2002, 53(3), 317-325.